Agendia: Elizabeth Hanna

Agendia said that it has appointed Elizabeth Hanna as executive vice president and chief commercial officer. Hanna most recently served as president and CEO at Clinical Genomics. Prior to that, she was president and COO at Origin, a clinical-stage biotech company. She has also previously held commercial and managerial roles at Johnson & Johnson Vision Care and Ortho Clinical Diagnostics, and currently serves on the board of directors for Treace Medical Concepts. She holds a BS in chemical engineering from the University of Illinois and an MBA from Harvard Business School.